Merck (Germany) Today
MRK Stock | EUR 140.45 0.15 0.11% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Merck is trading at 140.45 as of the 11th of December 2024. This is a 0.11 percent increase since the beginning of the trading day. The stock's lowest day price was 139.5. Merck has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2022 and ending today, the 11th of December 2024. Click here to learn more.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. MERCK KGAA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. The company has 129.24 M outstanding shares. More on Merck Company
Moving together with Merck Stock
Moving against Merck Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Merck Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Merck's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman | Kenneth Frazier |
Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Merck Company (MRK) is traded on Frankfurt Exchange in Germany and employs 63,723 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 73.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Merck Company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 129.24 M outstanding shares.
Merck Company has accumulated about 2.3 B in cash with 4.62 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.29.
Check Merck Probability Of Bankruptcy
Ownership AllocationMerck Company maintains a total of 129.24 Million outstanding shares. Over half of Merck's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Merck Company. Please watch out for any change in the institutional holdings of Merck Company as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Merck Ownership Details
Merck Company Risk Profiles
Although Merck's alpha and beta are two of the key measurements used to evaluate Merck's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.15 | |||
Standard Deviation | 1.7 | |||
Variance | 2.89 | |||
Risk Adjusted Performance | (0.11) |
Merck Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
All Next | Launch Module |
Merck Corporate Directors
Thomas Glocer | Independent Director | Profile | |
Christine Seidman | Independent Director | Profile | |
Kathy Warden | Independent Director | Profile | |
Paul Rothman | Independent Director | Profile |
Additional Information and Resources on Investing in Merck Stock
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.